Wharton's jelly mesenchymal stem cells promote wound healing and tissue regeneration

Stem Cell Research and Therapy

Volumn 5, Issue 3, 2014, Pages

  Kamolz, Lars Peter ^a   Keck, Maike ^b   Kasper, Cornelia ^c  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE DERIVED STEM CELL; ADULT STEM CELL; ALLOTRANSPLANTATION; CELL MIGRATION; CELL PROLIFERATION; EMBRYONIC STEM CELL; EPITHELIZATION; FIBROBLAST; GENE EXPRESSION; HUMAN; MESENCHYMAL STEM CELL; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; REVIEW; TISSUE REGENERATION; WHARTON JELLY; WOUND CLOSURE; WOUND HEALING; MESENCHYMAL STROMA CELL; PHYSIOLOGY; REGENERATION;

HUMANS; MESENCHYMAL STROMAL CELLS; REGENERATION; WHARTON JELLY; WOUND HEALING;

EID: 84899733600     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt451     Document Type: Review

References (10)

1. Human Wharton's jelly mesenchymal stem cells promote skin wound healing through pcrine signaling. AI Arno, S Amini-Nik, PH Blit, M Al-Shehab, C Belo, E Herer, CT Tien, MG Jeschke, Stem Cell Res Ther 2014 5 28 10.1186/scrt417 24564987
2. The properties of an 'ideal' burn wound dressing-what do we need in daily clinical practice? Results of a worldwide online survey among burn care specialists. HF Selig, DB Lumenta, M Giretzlehner, MG Jeschke, D Upton, LP Kamolz, Burns 2012 38 960 966 10.1016/j.burns.2012.04.007 22571855
3. Stem cell therapy: a new treatment for burns? A Arno, AH Smith, BH Blit, M Al-Shehab, G Gauglitz, MG Jeschke, Pharmaceuticals 2011 4 1355 1380 10.3390/ph4101355
4. Mechanisms of action of mesenchymal stem cells in cutaneous wound repair and regneration. H Li, X Fu, Cell Tissue Res 2012 348 371 377 10.1007/s00441-012-1393-9 22447168
5. Mesenchymal stem cell therapy for nonhealing cutaneous wounds. SE Hanson, ML Bentz, P Hematti, Plast Reconstr Surg 2010 125 510 516 10.1097/PRS. 0b013e3181c722bb 20124836
6. Differential response of human adipose tissue-derived mesenchymal stem cells, dermal fibroblasts, and keratinocytes to burn wound exudates: potential role of skin-specific chemokine CCL27. LJ van den Broek, KL Kroeze, T Waaijman, M Breetveld, SC Sampat-Sardjoepersad, FB Niessen, E Middelkoop, RJ Scheper, S Gibbs, Tissue Eng Part A 2014 20 197 209 10.1089/ten.tea.2013.0123 23980822
7. The therapeutic potential, challenges and future clinical directions of stem cells from the Wharton's jelly of the human umbilical cord. A Bongso, CY Fong, Stem Cell Rev 2013 9 226 240 10.1007/s12015-012-9418-z 23233233
8. Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. R Haas, C Kasper, S Bohm, R Jacobs, Cell Commun Signal 2011 9 12 10.1186/1478-811X-9-12 21569606
9. Long term effects of the implantation of Wharton's jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus. JYX Hu, Z Wang, L Wang, H Gao, Y Chen, W Zhao, Z Jia, S Yan, Y Wang, Endocr J 2013 60 347 357 10.1507/endocrj.EJ12-0343 23154532
10. Use of poly(DL-lactide-ε-caprolactone) membranes and mesenchymal stem cells from the Wharton's jelly of the umbilical cord for promoting nerve regeneration in axonotmesis: in vitro and in vivo analysis. A Gärtner, T Pereira, MG Alves, PA Armada-da-Silva, I Amorim, R Gomes, J Ribeiro, ML França, C Lopes, RA Carvalho, S Socorro, PF Oliveira, B Porto, R Sousa, A Bombaci, G Ronchi, F Fregnan, AS Varejão, AL Luís, S Geuna, AC Maurício, Differentiation 2012 84 355 365 10.1016/j.diff.2012.10.001 23142731